HOME >> BIOLOGY >> NEWS
Up to one-third of all cancer cases may be prevented by healthy diets and exercise, notes FANSA

CHICAGO -- Healthy diets and exercise may prevent as many cases of cancer in the United States as not smoking, according to a recent statement by the Food and Nutrition Science Alliance (FANSA). Cancer kills more than 500,000 Americans every year. In a review of cancer research, FANSA found overwhelmingly conclusive evidence that the risk of several types of cancer can be dramatically lowered through healthy dietary practices and exercise.

"In terms of cancer prevention, a healthy diet and exercise are as important as not smoking," says Dennis Savaiano, Ph.D., chair of FANSA and Professor of Foods and Nutrition at Purdue University. "Approximately one-third of cancer cases are attributed to smoking, one-third to poor diet and lack of exercise, and one-third to genetic or other factors. Most Americans are already aware of the detrimental effects of smoking, but poor diet is cause for alarm. We need to initiate changes in behavior now, in order to reduce the number of cancer-related deaths in the years to come."

The FANSA Statement, "Diet and Cancer Prevention in the United States," specifically urges Americans to take the following steps to reduce their cancer risk:

  • Eat plenty of fruits, vegetables, whole grains, and legumes in accordance with the USDA Food Guide Pyramid.
  • Avoid high calorie foods with little nutritional value.
  • Choose activities that involve moderate or vigorous exercise.
  • Limit or abstain from alcohol intake.

The FANSA statement, which can be viewed at www.faseb.org/ascn/fansa12-99.htm, is the first step in a nationwide call for action. In order to effect a change, all food, nutrition, fitness, health, and government organizations must strive to create consumer demand for a healthy lifestyle.


'"/>

Contact: Dennis Savaiano
savaiano@cfs.purdue.edu
765-494-8210
Institute of Food Technologists
23-Feb-2000


Page: 1

Related biology news :

1. Americans still consume one-third of calories from low-nutrient tip of the pyramid
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
Breaking Biology Technology:
Cached News: